시장보고서
상품코드
1181674

세계의 수면무호흡용 기기 시장 : 전망과 예측(2022-2027년)

Sleep Apnea Devices Market - Global Outlook & Forecast 2022-2027

발행일: | 리서치사: Arizton Advisory & Intelligence | 페이지 정보: 영문 341 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 수면무호흡용 기기 시장 규모는 2022-2027년에 CAGR로 7.07%의 성장이 예측됩니다.

세계의 수면무호흡용 기기 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인, 경쟁 구도 등을 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 조사 목적

제3장 조사 프로세스

제4장 범위

제5장 리포트 전제조건과 주의사항

제6장 시장의 개요

제7장 주요 인사이트

  • 시장의 개요
    • 시장 역학
    • 시장 세분화
    • 벤더 분석
    • 최근의 발전

제8장 서론

  • 개요
    • 위험인자
    • 수면무호흡 진단
    • 수면무호흡의 치료

제9장 시장 기회와 동향

제10장 시장 성장 촉진요인

제11장 시장 억제요인

제12장 시장 구도

  • 시장의 개요
  • 시장 규모와 예측
    • 인사이트 : 지역별
    • 인사이트 : 제품별
    • 인사이트 : 연령층별
    • 인사이트 : 성별
    • 인사이트 : 최종사용자별
  • Five forces 분석

제13장 제품

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 치료 기기
  • 페이셜 인터페이스
  • 진단 기기

제14장 연령층

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 41세-60세
  • 61세 이상
  • 40세 미만

제15장 성별

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 남성
  • 여성

제16장 최종사용자

  • 시장 스냅숏과 성장 엔진
  • 시장의 개요
  • 수면 클리닉/연구소
  • 재택의료 환경
  • 병원
  • 기타

제17장 지역

  • 시장 스냅숏과 성장 엔진
  • 지역적 개요

제18장 북미

  • 시장의 개요
  • 시장 규모와 예측
    • 북미 : 제품 북미
    • 북미 : 연령층별
    • 북미 : 성별
    • 북미 : 최종사용자별
  • 주요 국가
    • 미국 : 시장 규모와 예측
    • 캐나다 : 시장 규모와 예측

제19장 유럽

  • 시장의 개요
  • 시장 규모와 예측
    • 유럽 : 제품별
    • 유럽 : 연령층별
    • 유럽 : 성별
    • 유럽 : 최종사용자별
  • 주요 국가
    • 독일 : 시장 규모와 예측
    • 프랑스 : 시장 규모와 예측
    • 영국 : 시장 규모와 예측
    • 이탈리아 : 시장 규모와 예측
    • 스페인 : 시장 규모와 예측

제20장 아시아태평양

  • 시장의 개요
  • 시장 규모와 예측
    • 아시아태평양 : 제품별
    • 아시아태평양 : 연령층별
    • 아시아태평양 : 성별
    • 아시아태평양 : 최종사용자별
  • 주요 국가
    • 중국 : 시장 규모와 예측
    • 일본 : 시장 규모와 예측
    • 인도 : 시장 규모와 예측
    • 한국 : 시장 규모와 예측
    • 호주 : 시장 규모와 예측

제21장 라틴아메리카

  • 시장의 개요
  • 시장 규모와 예측
    • 라틴아메리카 : 제품별
    • 라틴아메리카 : 연령층별
    • 라틴아메리카 : 성별
    • 라틴아메리카 : 최종사용자별
  • 주요 국가
    • 브라질 : 시장 규모와 예측
    • 멕시코 : 시장 규모와 예측
    • 아르헨티나 : 시장 규모와 예측

제22장 중동·아프리카

  • 시장의 개요
  • 시장 규모와 예측
    • 중동·아프리카 : 제품별
    • 중동·아프리카 : 연령층별
    • 중동·아프리카 : 성별
    • 중동·아프리카 : 최종사용자별
  • 주요 국가
    • 터키 : 시장 규모와 예측
    • 사우디아라비아 : 시장 규모와 예측
    • 남아프리카공화국 : 시장 규모와 예측

제23장 경쟁 구도

  • 경쟁의 개요
  • 시장 점유율 분석

제24장 주요 기업 개요

  • NIHON KOHDEN CORPORATION
  • BMC MEDICAL
  • DRIVE DEVILBISS HEALTHCARE
  • SOMNOMED
  • GLIDEWELL
  • RESMED
  • KONINKLIJKE PHILIPS N.V
  • FISHER & PAYKEL HEALTHCARE
  • COMPUMEDICS LIMITED
  • INSPIRE MEDICAL SYSTEMS
  • NATUS MEDICAL
  • ITAMAR MEDICAL

제25장 기타 유명 벤더

  • APEX MEDICAL
  • CADWELL INDUSTRIES
  • SOMNOMEDICS
  • CLEVELAND MEDICAL DEVICES
  • PROSOMNUS SLEEP TECHNOLOGIES
  • MEDITAS
  • WHITE DENTAL HEALTHCARE
  • OVENTUS
  • TOMED
  • SIGNIFIER MEDICAL TECHNOLOGIES
  • APNEAMED
  • NYXOAH
  • VIVOS THERAPEUTICS
  • SOMNOWELL
  • REMSLEEP HOLDINGS
  • SIESTA MEDICAL
  • HORIZON PRIME
  • NOX MEDICAL
  • ONERA HEALTH
  • LIVANOVA
  • ZOLL MEDICAL
  • BRAEBON MEDICAL
  • INVACARE
  • BREAS MEDICAL

제26장 리포트 요약

  • 주요 사항
  • 전략적 권장사항

제27장 정량적 요약

제28장 부록

KSA 23.01.19

The global sleep apnea devices market is expected to grow at a CAGR of 7.07% during 2022-2027.

MARKET OUTLOOK

The growing sleep apnea devices market is attributed to factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological advancements in sleep apnea devices, and an increasingly aging population. Obstructive sleep apnea (OSA) is particularly prevalent in adults with mild to moderate severity (14% in men and 5% in women) and is becoming more common, partly due to the increasing prevalence of obesity worldwide. The global prevalence of OSA is estimated at 1 billion people, and in some countries, the prevalence in the general population is estimated to exceed 50%.

In developed regions such as North America and Europe, sleep apnea devices are already widely held for OSA. The sleep apnea devices market in these regions is witnessing the entry of many new players and start-ups, promising to provide different products that meet customer demand and market trends. The current trend is smart sleep apnea devices, which are being explored by existing and new players in the market.

The increasing prevalence of obesity and other lifestyle diseases in both developed and developing countries and the rising rate of diagnosis of sleep apnea is presenting a larger patient demographic which requires treatment or management of sleep apnea. This, combined with the increasing number of sleep physicians, technicians, and sleep clinics globally, is facilitating the global sleep apnea devices market's growth.

MARKET TRENDS & OPPORTUNITIES

The Emergence of Artificial Intelligence in Sleep Apnea Treatment

  • The convergence of large data sets, increased computing power, and algorithm advances have opened the door to Artificial intelligence (AI) applications across various industries.
  • AHI is only a consideration, and the ability to predict side effects and response to treatment is limited. AI offers the opportunity to consider more factors than AHI. AHI provides more information about the severity and OSA endophenotype and can influence treatment choices.
  • Artificial intelligence (AI) will pave the way for screening and diagnosing OSA, reduce costly PSG deployment, and streamline the path to effective treatment in the sleep apnea devices market.

Growing Demand and Advancements in Home Sleep Apnea Tests (HSATs)

  • In December 2007, the American Academy of Sleep Medicine (AASM) task force published guidelines for the use of unattended wearable monitors (PM) for the diagnosis of obstructive sleep apnea (OSA) in adults. In March 2017, considering recent technological advances in the sleep apnea devices market, the AASM revised its guidelines to include home sleep testing (HST) measuring peripheral arterial tonometry (PAT), oximetry, and actigraphy in obstructive sleep.
  • Itamar Medical, a leading player in the sleep apnea diagnostics market, offers WatchPat, the market-leading sleep apnea diagnostic device that uses this proprietary PAT technology.
  • ResMed launches a three-part "Onesleeptest" service for NightOwl after acquiring the device's manufacturer Ectosense. The onesleeptest device accurately tracks and delivers results from a certified sleep specialist within 3-5 business days, making it the ideal solution for testing sleep quality from the comfort and safety of their own home during the pandemic.

Technological Advancements in Continuous Positive Airway Pressure (CPAP) Therapy

  • CPAP has changed significantly since its inception in 1981. Devices developed decades ago were heavier, noisier, and had limited performance compared to today's slim, lightweight devices.
  • An outstanding innovation is the Automatic Airway Pressure Device (AutoPAP); with AutoPAP, airway pressure begins with light to meet lower pressure needs. When a patient falls asleep, the device automatically adjusts to increase positive airway pressure and keep the respiratory system open. Some CPAP machines in the sleep apnea devices market have the intellectual ability to record the mask on time when the patient breathes into the mask, when the air supply is started and when the mask is removed, and the air stops.
  • Another notable feature of CPAP today is its low noise level. In addition to size and weight, the CPAP machine's ability to deliver 20 cm H2O-filtered air to patients with a slight humping is just as refreshing for doctors, patients, and bed partners. The days of sleeping next to mechanically generated hurricanes are over; thanks to a lightweight blower, it is well insulated with CPAP machines.

SEGMENTATION INSIGHTS

PRODUCTS INSIGHTS

The therapeutic devices segment accounts for the highest share of 73.98% in the global sleep apnea devices market by products segment. The therapeutics device segment comprises positive airway pressure (PAP) devices, oral appliances, adaptive servo-ventilators, implants, airway clearance systems, oxygen therapy devices, & accessories. The prevalence of OSA is increasing significantly in developed and developing countries. The prevalence of OSA is rising due to the exponentially growing potential risk factors such as obesity, the aging population, smoking, a sedentary lifestyle, etc. Positive airway pressure (PAP) therapy is a common term used for all sleep apnea treatments that use compressed air flow to support the airways during sleep. The PAP machines continuously witness technological advancements; for instance, these devices combine the variable positive air pressure (VPAP), a relatively new technology, with the automatic adjustments of classic BiPAP therapy's dual-level pressure settings.

The global sleep apnea devices market by facial interfaces was valued at USD 916.7 million in 2021. Continuous positive airway pressure (CPAP) masks and headgear are available in various styles and sizes to help treat sleep apnea. Because everyone's needs, preferences, and face shapes are different, patients may need to try different mask styles before finding the one that works best for them. A mask is used to direct air through the therapy device. Most masks have built-in vents to expel exhaled air.

Segmentation by Product:

  • Therapeutic Devices
  • Facial Interfaces
  • Diagnostics Devices

AGE GROUP INSIGHTS

The global sleep apnea devices market by age group is segmented into between 41 & 60 years, 61 years & above, and below 40 years. Between 41 & 60 years accounted for a larger share, 51.06% in the global market. The 41-60 years of the age group of people are the working adult population facing daily issues from the workplace to the home. The major risk factors for developing OSA and its related symptoms, like snoring in this age group, are work-related stress, alcohol consumption, chronic smoking, and obesity.

Segmentation by Age Group:

  • Between 41 & 60 Years
  • 61 Years & Above
  • Below 40 Years

GENDER INSIGHTS

The male segment accounted for the highest share of 60.50% in the global sleep apnea devices market by gender segment. OSA is the usual sleep-related breathing disorder, and it is most common in older males. In North America, the estimated prevalence is about 15-30% in males. Most patients with OSA complain of daytime sleepiness or report loud snoring, wheezing, choking, sniffling, or cessation of breathing while their bed partner sleeps. These symptoms are often identified during assessment for another condition, wellness maintenance, or preoperative screening. Women report greater reporting of OSA symptoms for their bed partners. Obesity is a significant risk factor for sleep apnea, and most OSA patients are overweight. Men are more likely than women to increase AHI for a given weight gain, regardless of baseline weight, waist size, age, or race. The global male sleep apnea devices market is expected to grow at a CAGR of 7.30% during the forecast period.

Segmentation by Gender:

  • Males
  • Females

END-USER INSIGHTS

Among all end-users, the sleep clinics/labs segment accounted for the highest share of 39.14% in the global sleep apnea devices market. With the increasing prevalence of sleep disorders, the requirement for sleep labs is also rising. Accurate diagnosis is essential for the determination of sleeping disorders. Because of higher medical accuracy, polysomnography (PSG) is the most preferred technology for diagnosis.

With the increasing incidences of sleeping disorders, the demand for sleep facilities and clinics equipped with technologically advanced PSGs is increasing. Nearly 3,500 sleep labs or clinics have been established across the US since they began in the 1970s. The American Academy of Sleep Medicine has accredited about 1,400 of these facilities. The need for these facilities is supported by research; recent findings relate sleep disturbances to an increased risk of heart attack, stroke, diabetes, rheumatoid arthritis, metabolic disorders, and other illnesses.

Segmentation by End-User:

  • Sleep Clinics/Labs
  • Home Healthcare Settings
  • Hospitals
  • Others

GEOGRAPHICAL INSIGHTS

The global sleep apnea devices market is categorized into regions of North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2021, North America dominated the global market and accounted for a revenue share of 40.43%. The region's market growth depends on various factors, including a high prevalence of sleep disorders, a decrease in sleep patterns, lifestyle changes, and the presence of various vendors, including key players, start-ups, and sleep-based companies. The region has witnessed a high prevalence of OSA; for instance, the prevalence of OSA in North America is nearly 15 to 30% in men and 10 to 15% in women. The presence of sleep apnea device manufacturers boosts the region's market share, making it more significant than any other region globally.

Europe's sleep apnea devices market was valued at USD 1.9 billion in 2021. In Europe, the market is driven by the growing use of technology to manage sleep disorders. Technology, such as PAP devices, innovative OAT devices, and diagnostics devices, is getting traction in the European market. APAC proves to be the region with the fastest growth rate among other regions. It is expected to continue its growth during the forecast period and affect the global sleep apnea devices market with its power to manufacture large-scale products. China, Japan, and India are the leading countries in the APAC sleep apnea device, where China is dominating the sleep apnea devices market with its innovative solutions.

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

VENDOR LANDSCAPE

The global sleep apnea devices market is highly diversified, with several global and local players offering a diverse range of sleep apnea devices such as PAP devices, oral devices, implants, and other devices. The global players focus on developing innovative products and expanding their product portfolio to remain competitive. They are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers in the global sleep apnea devices market, such as ResMed, Koninklijke Philips N.V, BMC Medical Natus Medical, Itamar Medical, inspire medical system, Compumedics, and Drive DeVilbiss Healthcare, are continuously focusing on product development and offering sophisticated sleep apnea device with new technology to increase their industry presence.

Key Company Profiles

  • Nihon Kohden Corporation
  • BMC Medical
  • Drive DeVilbiss Healthcare
  • SomnoMed
  • Glidewell
  • ResMed
  • Koninklijke Philips N.V
  • Fisher & Paykel Healthcare
  • Compumedics Limited
  • Inspire Medical Systems
  • Natus Medical
  • Itamar Medical

Other Prominent Vendors

  • Apex Medical
  • Cadwell Industries
  • SOMNOmedics
  • Cleveland Medical Devices
  • ProSomnus Sleep Technologies
  • MEDITAS
  • White Dental Healthcare
  • Oventus
  • Tomed
  • Signifier Medical Technologies
  • ApneaMed
  • Nyxoah
  • Vivos Therapeutics
  • Somnowell
  • RemSleep Holdings
  • Siesta Medical
  • Horizon Prime
  • Nox Medical
  • Onera Health
  • LivaNova
  • ZOLL Medical
  • BRAEBON Medical
  • Invacare
  • Breas Medical

Recent Advancements In The Global Sleep Apnea Devices Market

  • In April 2022, Fisher & Paykel Healthcare announced the launch of the F&P Evora Full in the US, a compact full-face mask for OSA.
  • In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to bring Oventus' OSA treatment solutions, including O2Vent Optima, directly to consumers through US sleep clinics.
  • In August 2021, ResMed launched a new PAP device in the US sleep apnea devices market to help hundreds of millions of people with sleep apnea.
  • In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy through GoPAPfree in the US.
  • In December 2021, ZOLL Medical Corporation, a subsidiary of Asahi Kasei that manufactures medical devices and related software solutions, announced the acquisition of Itamar Medical Ltd., a medical device and digital health company that provides home testing services.

KEY QUESTIONS ANSWERED

  • 1. How big is the sleep apnea market?
  • 2. What is the growth rate of the global sleep apnea devices market?
  • 3. What are the rising trends in the sleep apnea devices market?
  • 4. Which are the key companies in the global sleep apnea devices market?
  • 5. Which are the popular CPAP devices available in the market?
  • 6. Which holds the most significant global sleep apnea devices market share?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

  • 7.1 MARKET OVERVIEW
    • 7.1.1 MARKET DYNAMICS
    • 7.1.2 MARKET SEGMENTATION
    • 7.1.3 VENDOR ANALYSIS
    • 7.1.4 RECENT ADVANCES

8 INTRODUCTION

  • 8.1 OVERVIEW
    • 8.1.1 RISK FACTORS
    • 8.1.2 DIAGNOSIS OF SLEEP APNEA
    • 8.1.3 TREATMENT FOR SLEEP APNEA

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 IMPLEMENTATION OF AI IN SLEEP APNEA TREATMENTS
  • 9.2 GROWING DEMAND AND ADVANCES IN HOME SLEEP APNEA TESTS (HSATS)
  • 9.3 GROWING ADOPTION OF TELEMEDICINE, MHEALTH IN SLEEP APNEA TREATMENT
  • 9.4 GROWING POPULARITY OF NON-CPAP DEVICES FOR SLEEP APNEA TREATMENT

10 MARKET GROWTH ENABLERS

  • 10.1 IMPROVEMENTS IN SLEEP APNEA DIAGNOSIS
  • 10.2 TECHNOLOGICAL ADVANCES IN CPAP THERAPY
  • 10.3 INCREASING TARGET PATIENT POPULATION
  • 10.4 HIGH GROWTH POTENTIAL FOR UPPER AIRWAY STIMULATION THERAPY (IMPLANT) SYSTEM

11 MARKET RESTRAINTS

  • 11.1 PRESENCE OF NUMEROUS UNDIAGNOSED PATIENTS
  • 11.2 HIGH COST OF SLEEP APNEA DEVICES
  • 11.3 AVAILABILITY OF SURGICAL OPTION TO TREAT SLEEP APNEA
  • 11.4 LACK OF PATIENT ADHERENCE TO CPAP DEVICE

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
    • 12.2.1 INSIGHTS BY GEOGRAPHY SEGMENTATION
    • 12.2.2 INSIGHTS BY PRODUCT SEGMENTATION
    • 12.2.3 INSIGHTS BY AGE GROUP SEGMENTATION
    • 12.2.4 INSIGHTS BY GENDER SEGMENTATION
    • 12.2.5 INSIGHTS BY END-USER SEGMENTATION
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 THERAPEUTIC DEVICES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 FACIAL INTERFACES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 DIAGNOSTICS DEVICES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY

14 AGE GROUP

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 BETWEEN 41 & 60 YEARS
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 61 YEARS & ABOVE
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 BELOW 40 YEARS
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY

15 GENDER

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 MARKET OVERVIEW
  • 15.3 MALES
    • 15.3.1 MARKET OVERVIEW
    • 15.3.2 MARKET SIZE & FORECAST
    • 15.3.3 MARKET BY GEOGRAPHY
  • 15.4 FEMALES
    • 15.4.1 MARKET OVERVIEW
    • 15.4.2 MARKET SIZE & FORECAST
    • 15.4.3 MARKET BY GEOGRAPHY

16 END-USER

  • 16.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 16.2 MARKET OVERVIEW
  • 16.3 SLEEP CLINICS/LABS
    • 16.3.1 MARKET OVERVIEW
    • 16.3.2 MARKET SIZE & FORECAST
    • 16.3.3 MARKET BY GEOGRAPHY
  • 16.4 HOME HEALTHCARE SETTINGS
    • 16.4.1 MARKET OVERVIEW
    • 16.4.2 MARKET SIZE & FORECAST
    • 16.4.3 MARKET BY GEOGRAPHY
  • 16.5 HOSPITALS
    • 16.5.1 MARKET OVERVIEW
    • 16.5.2 MARKET SIZE & FORECAST
    • 16.5.3 MARKET BY GEOGRAPHY
  • 16.6 OTHERS
    • 16.6.1 MARKET OVERVIEW
    • 16.6.2 MARKET SIZE & FORECAST
    • 16.6.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

  • 17.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
    • 18.2.1 NORTH AMERICA: PRODUCT SEGMENTATION
    • 18.2.2 NORTH AMERICA: AGE GROUP SEGMENTATION
    • 18.2.3 NORTH AMERICA: GENDER SEGMENTATION
    • 18.2.4 NORTH AMERICA: END USER SEGMENTATION
  • 18.3 KEY COUNTRIES
    • 18.3.1 US: MARKET SIZE & FORECAST
    • 18.3.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
    • 19.2.1 EUROPE: PRODUCT SEGMENTATION
    • 19.2.2 EUROPE: AGE GROUP SEGMENTATION
    • 19.2.3 EUROPE: GENDER SEGMENTATION
    • 19.2.4 EUROPE: END USER SEGMENTATION
  • 19.3 KEY COUNTRIES
    • 19.3.1 GERMANY: MARKET SIZE & FORECAST
    • 19.3.2 FRANCE: MARKET SIZE & FORECAST
    • 19.3.3 UK: MARKET SIZE & FORECAST
    • 19.3.4 ITALY: MARKET SIZE & FORECAST
    • 19.3.5 SPAIN: MARKET SIZE & FORECAST

20 APAC

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
    • 20.2.1 APAC: PRODUCT SEGMENTATION
    • 20.2.2 APAC: AGE GROUP SEGMENTATION
    • 20.2.3 APAC: GENDER SEGMENTATION
    • 20.2.4 APAC: END USER SEGMENTATION
  • 20.3 KEY COUNTRIES
    • 20.3.1 CHINA: MARKET SIZE & FORECAST
    • 20.3.2 JAPAN: MARKET SIZE & FORECAST
    • 20.3.3 INDIA: MARKET SIZE & FORECAST
    • 20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
    • 20.3.5 AUSTRALIA: MARKET SIZE & FORECAST

21 LATIN AMERICA

  • 21.1 MARKET OVERVIEW
  • 21.2 MARKET SIZE & FORECAST
    • 21.2.1 LATIN AMERICA: PRODUCT SEGMENTATION
    • 21.2.2 LATIN AMERICA: AGE GROUP SEGMENTATION
    • 21.2.3 LATIN AMERICA: GENDER SEGMENTATION
    • 21.2.4 LATIN AMERICA: END USER SEGMENTATION
  • 21.3 KEY COUNTRIES
    • 21.3.1 BRAZIL: MARKET SIZE & FORECAST
    • 21.3.2 MEXICO: MARKET SIZE & FORECAST
    • 21.3.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

  • 22.1 MARKET OVERVIEW
  • 22.2 MARKET SIZE & FORECAST
    • 22.2.1 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
    • 22.2.2 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION
    • 22.2.3 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
    • 22.2.4 MIDDLE EAST & AFRICA: END USER SEGMENTATION
  • 22.3 KEY COUNTRIES
    • 22.3.1 TURKEY: MARKET SIZE & FORECAST
    • 22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
    • 22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

  • 23.1 COMPETITION OVERVIEW
  • 23.2 MARKET SHARE ANALYSIS

24 KEY COMPANY PROFILES

  • 24.1 NIHON KOHDEN CORPORATION
    • 24.1.1 BUSINESS OVERVIEW
    • 24.1.2 NIHON KOHDEN CORPORATION IN SLEEP APNEA MARKET
    • 24.1.3 PRODUCT OFFERINGS
    • 24.1.4 KEY STRATEGIES
    • 24.1.5 KEY STRENGTHS
    • 24.1.6 KEY OPPORTUNITIES
  • 24.2 BMC MEDICAL
    • 24.2.1 BUSINESS OVERVIEW
    • 24.2.2 BMC MEDICAL IN SLEEP APNEA MARKET
    • 24.2.3 PRODUCT OFFERINGS
    • 24.2.4 KEY STRATEGIES
    • 24.2.5 KEY STRENGTHS
    • 24.2.6 KEY OPPORTUNITIES
  • 24.3 DRIVE DEVILBISS HEALTHCARE
    • 24.3.1 BUSINESS OVERVIEW
    • 24.3.2 DRIVE DEVILBISS HEALTHCARE IN SLEEP APNEA MARKET
    • 24.3.3 PRODUCT OFFERINGS
    • 24.3.4 KEY STRATEGIES
    • 24.3.5 KEY STRENGTHS
    • 24.3.6 KEY OPPORTUNITIES
  • 24.4 SOMNOMED
    • 24.4.1 BUSINESS OVERVIEW
    • 24.4.2 SOMNOMED IN SLEEP APNEA MARKET
    • 24.4.3 PRODUCT OFFERINGS
    • 24.4.4 KEY STRATEGIES
    • 24.4.5 KEY STRENGTHS
    • 24.4.6 KEY OPPORTUNITIES
  • 24.5 GLIDEWELL
    • 24.5.1 BUSINESS OVERVIEW
    • 24.5.2 GLIDEWELL IN SLEEP APNEA MARKET
    • 24.5.3 PRODUCT OFFERINGS
    • 24.5.4 KEY STRATEGIES
    • 24.5.5 KEY STRENGTHS
    • 24.5.6 KEY OPPORTUNITIES
  • 24.6 RESMED
    • 24.6.1 BUSINESS OVERVIEW
    • 24.6.2 RESMED IN SLEEP APNEA MARKET
    • 24.6.3 PRODUCT OFFERINGS
    • 24.6.4 KEY STRATEGIES
    • 24.6.5 KEY STRENGTHS
    • 24.6.6 KEY OPPORTUNITIES
  • 24.7 KONINKLIJKE PHILIPS N.V
    • 24.7.1 BUSINESS OVERVIEW
    • 24.7.2 KONINKLIJKE PHILIPS N.V IN SLEEP APNEA MARKET
    • 24.7.3 PRODUCT OFFERINGS
    • 24.7.4 KEY STRATEGIES
    • 24.7.5 KEY STRENGTHS
    • 24.7.6 KEY OPPORTUNITIES
  • 24.8 FISHER & PAYKEL HEALTHCARE
    • 24.8.1 BUSINESS OVERVIEW
    • 24.8.2 FISHER & PAYKEL HEALTHCARE IN SLEEP APNEA MARKET
    • 24.8.3 PRODUCT OFFERINGS
    • 24.8.4 KEY STRATEGIES
    • 24.8.5 KEY STRENGTHS
    • 24.8.6 KEY OPPORTUNITIES
  • 24.9 COMPUMEDICS LIMITED
    • 24.9.1 BUSINESS OVERVIEW
    • 24.9.2 COMPUMEDICS IN SLEEP APNEA MARKET
    • 24.9.3 PRODUCT OFFERINGS
    • 24.9.4 KEY STRATEGIES
    • 24.9.5 KEY STRENGTHS
    • 24.9.6 KEY OPPORTUNITIES
  • 24.10 INSPIRE MEDICAL SYSTEMS
    • 24.10.1 BUSINESS OVERVIEW
    • 24.10.2 INSPIRE MEDICAL SYSTEMS IN SLEEP APNEA MARKET
    • 24.10.3 PRODUCT OFFERINGS
    • 24.10.4 KEY STRATEGIES
    • 24.10.5 KEY STRENGTHS
    • 24.10.6 KEY OPPORTUNITIES
  • 24.11 NATUS MEDICAL
    • 24.11.1 BUSINESS OVERVIEW
    • 24.11.2 NATUS MEDICAL IN SLEEP APNEA MARKET
    • 24.11.3 PRODUCT OFFERINGS
    • 24.11.4 KEY STRATEGIES
    • 24.11.5 KEY STRENGTHS
    • 24.11.6 KEY OPPORTUNITIES
  • 24.12 ITAMAR MEDICAL
    • 24.12.1 BUSINESS OVERVIEW
    • 24.12.2 ITAMAR MEDICAL IN SLEEP APNEA DEVICES MARKET
    • 24.12.3 PRODUCT OFFERINGS
    • 24.12.4 KEY STRATEGIES
    • 24.12.5 KEY STRENGTHS
    • 24.12.6 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

  • 25.1 APEX MEDICAL
    • 25.1.1 BUSINESS OVERVIEW
    • 25.1.2 PRODUCT OFFERINGS
  • 25.2 CADWELL INDUSTRIES
    • 25.2.1 BUSINESS OVERVIEW
    • 25.2.2 PRODUCT OFFERINGS
  • 25.3 SOMNOMEDICS
    • 25.3.1 BUSINESS OVERVIEW
    • 25.3.2 PRODUCT OFFERINGS
  • 25.4 CLEVELAND MEDICAL DEVICES
    • 25.4.1 BUSINESS OVERVIEW
    • 25.4.2 PRODUCT OFFERINGS
  • 25.5 PROSOMNUS SLEEP TECHNOLOGIES
    • 25.5.1 BUSINESS OVERVIEW
    • 25.5.2 PRODUCT OFFERINGS
  • 25.6 MEDITAS
    • 25.6.1 BUSINESS OVERVIEW
    • 25.6.2 PRODUCT OFFERINGS
  • 25.7 WHITE DENTAL HEALTHCARE
    • 25.7.1 BUSINESS OVERVIEW
    • 25.7.2 PRODUCT OFFERINGS
  • 25.8 OVENTUS
    • 25.8.1 BUSINESS OVERVIEW
    • 25.8.2 PRODUCT OFFERINGS
  • 25.9 TOMED
    • 25.9.1 BUSINESS OVERVIEW
    • 25.9.2 PRODUCT OFFERINGS
  • 25.10 SIGNIFIER MEDICAL TECHNOLOGIES
    • 25.10.1 BUSINESS OVERVIEW
    • 25.10.2 PRODUCT OFFERINGS
  • 25.11 APNEAMED
    • 25.11.1 BUSINESS OVERVIEW
    • 25.11.2 PRODUCT OFFERINGS
  • 25.12 NYXOAH
    • 25.12.1 BUSINESS OVERVIEW
    • 25.12.2 PRODUCT OFFERINGS
  • 25.13 VIVOS THERAPEUTICS
    • 25.13.1 BUSINESS OVERVIEW
    • 25.13.2 PRODUCT OFFERINGS
  • 25.14 SOMNOWELL
    • 25.14.1 BUSINESS OVERVIEW
    • 25.14.2 PRODUCT OFFERINGS
  • 25.15 REMSLEEP HOLDINGS
    • 25.15.1 BUSINESS OVERVIEW
    • 25.15.2 PRODUCT OFFERINGS
  • 25.16 SIESTA MEDICAL
    • 25.16.1 BUSINESS OVERVIEW
    • 25.16.2 PRODUCT OFFERINGS
  • 25.17 HORIZON PRIME
    • 25.17.1 BUSINESS OVERVIEW
    • 25.17.2 PRODUCT OFFERINGS
  • 25.18 NOX MEDICAL
    • 25.18.1 BUSINESS OVERVIEW
    • 25.18.2 PRODUCT OFFERINGS
  • 25.19 ONERA HEALTH
    • 25.19.1 BUSINESS OVERVIEW
    • 25.19.2 PRODUCT OFFERINGS
  • 25.20 LIVANOVA
    • 25.20.1 BUSINESS OVERVIEW
    • 25.20.2 PRODUCT OFFERINGS
  • 25.21 ZOLL MEDICAL
    • 25.21.1 BUSINESS OVERVIEW
    • 25.21.2 PRODUCT OFFERINGS
  • 25.22 BRAEBON MEDICAL
    • 25.22.1 BUSINESS OVERVIEW
    • 25.22.2 PRODUCT OFFERINGS
  • 25.23 INVACARE
    • 25.23.1 BUSINESS OVERVIEW
    • 25.23.2 PRODUCT OFFERINGS
  • 25.24 BREAS MEDICAL
    • 25.24.1 BUSINESS OVERVIEW
    • 25.24.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

  • 26.1 KEY TAKEAWAYS
  • 26.2 STRATEGIC RECOMMENDATIONS.

27 QUANTITATIVE SUMMARY

  • 27.1 MARKET BY PRODUCT
    • 27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION
    • 27.1.2 EUROPE: PRODUCT SEGMENTATION
    • 27.1.3 APAC: PRODUCT SEGMENTATION
    • 27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION
    • 27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
  • 27.2 MARKET BY AGE GROUP
    • 27.2.1 NORTH AMERICA: AGE GROUP SEGMENTATION
    • 27.2.2 EUROPE: AGE GROUP SEGMENTATION
    • 27.2.3 APAC: AGE GROUP SEGMENTATION
    • 27.2.4 LATIN AMERICA: AGE GROUP SEGMENTATION
    • 27.2.5 MIDDLE EAST & AFRICA: AGE GROUP SEGMENTATION
  • 27.3 MARKET BY GENDER
    • 27.3.1 NORTH AMERICA: GENDER SEGMENTATION
    • 27.3.2 EUROPE: GENDER SEGMENTATION
    • 27.3.3 APAC: GENDER SEGMENTATION
    • 27.3.4 LATIN AMERICA: GENDER SEGMENTATION
    • 27.3.5 MIDDLE EAST & AFRICA: GENDER SEGMENTATION
  • 27.4 MARKET BY END USER
    • 27.4.1 NORTH AMERICA: END USER SEGMENTATION
    • 27.4.2 EUROPE: END USER SEGMENTATION
    • 27.4.3 APAC: END USER SEGMENTATION
    • 27.4.4 LATIN AMERICA: END USER SEGMENTATION
    • 27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION
  • 27.5 MARKET BY GEOGRAPHY
    • 27.5.1 THERAPEUTIC DEVICES: GEOGRAPHY SEGMENTATION
    • 27.5.2 FACIAL INTERFACES: GEOGRAPHY SEGMENTATION
    • 27.5.3 DIAGNOSTICS DEVICE: GEOGRAPHY SEGMENTATION
    • 27.5.4 BETWEEN 41 & 60 YEARS: GEOGRAPHY SEGMENTATION
    • 27.5.5 61 YEARS & ABOVE: GEOGRAPHY SEGMENTATION
    • 27.5.6 BELOW 40 YEARS: GEOGRAPHY SEGMENTATION
    • 27.5.7 MALES: GEOGRAPHY SEGMENTATION
    • 27.5.8 FEMALES: GEOGRAPHY SEGMENTATION
    • 27.5.9 SLEEP CLINICS/LABS: GEOGRAPHY SEGMENTATION
    • 27.5.10 HOME HEALTHCARE SETTINGS: GEOGRAPHY SEGMENTATION
    • 27.5.11 HOSPITALS: GEOGRAPHY SEGMENTATION
    • 27.5.12 OTHERS: GEOGRAPHY SEGMENTATION

28 APPENDIX

  • 28.1 ABBREVIATIONS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제